Lakeside Holding LTD 8-K filings

Quanome Technologies, Inc. has launched a new corporate identity and expanded its strategic focus to encompass quantum computing, AI, and advanced simulation, with its stock now trading under the ticker QNME.

Quanome Technologies, Inc. (formerly Lakeside Holding Limited) has officially changed its corporate name and updated its bylaws, effective August 3, 2026, with trading under the new symbol QNME commencing August 4, 2026.

Lakeside Holding Limited has received an additional 180-day period from Nasdaq to regain compliance with the minimum bid price requirement.

Lakeside Holding Limited has amended its Articles of Incorporation to significantly increase authorized common stock and authorize blank check preferred stock.

Lakeside Holding Limited received a notice from Nasdaq regarding its failure to meet the minimum $1.00 bid price requirement for continued listing.

Lakeside Holding Limited announced a private placement of 5.6 million common shares at $0.14 each, raising $784,000 for general corporate purposes.

Lakeside Holding Limited announced a private placement of 8.4 million shares at $0.70 each, raising $5.88 million for general corporate purposes, alongside the appointment of Mr. Yang Li as Joint Chief Executive Officer.

Lakeside Holding Limited stockholders rejected proposals to increase authorized common and preferred stock but approved a new treasury reserve strategy, future share issuances, and an equity incentive plan.

Lakeside Holding Limited announced the appointment of seasoned technology and business leader Mr. Aik Siang Goh to its Board of Directors, following the resignation of Ms. Yiye Zhou.

Lakeside Holding Limited announced it has regained compliance with Nasdaq's minimum bid price requirement, resolving a previously reported deficiency.

Lakeside Holding Limited announced significant changes to its leadership, including a new Chairman, Chief Operating Officer, and an independent director, effective immediately.

Lakeside Holding Limited announced the resignation of Ms. Cynthia Vuong from its Board of Directors and all committee memberships, effective August 15, 2025.

Lakeside Holding Limited filed an amendment to clarify its private placement, revealing more shares issued at a lower price per share.

Lakeside Holding Limited announced a private placement of 1,807,229 common shares at $0.83 per share, raising approximately $1.5 million for general corporate purposes.

Lakeside Holding Limited received a notice from Nasdaq regarding non-compliance with the minimum $1.00 bid price requirement, initiating a 180-day compliance period.

Lakeside Holding Limited announced it has regained compliance with Nasdaq's minimum shareholders' equity requirement, avoiding potential delisting.

Lakeside Holding Limited has successfully closed a private placement, raising approximately $1.5 million through the sale of 1.5 million common shares to bolster its general corporate operations.

Lakeside Holding Limited announced that its stockholders elected five directors to the company's board at the annual meeting held on June 26, 2025, with a significant majority of shares represented.

Lakeside Holding Limited announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement by issuing 3,000,000 shares for approximately $3 million.

Lakeside Holding Limited announced it has entered into a securities purchase agreement to sell 3 million shares of common stock in a private placement, raising approximately $3 million for general corporate purposes.

Lakeside Holding Limited announced its fiscal 2025 third quarter results, revealing a revenue decrease due to shifts in global shipping demands, partially offset by contributions from its new pharmaceutical distribution segment.

Lakeside Holding Limited completed a subsequent closing of its first tranche, issuing a $500,000 note and warrants to an institutional investor.

Lakeside Holding Limited reports the resignation of two board members and the appointment of two new directors, effective March 14, 2025.

Lakeside Holding Limited announces a securities purchase agreement for up to $4.5 million in convertible debt financing with warrant coverage to bolster working capital.

Lakeside Holding Limited received a notification from Nasdaq regarding non-compliance with minimum stockholders' equity requirements for continued listing.

Lakeside Holding Limited announces a decrease in total revenues for Q2 2025, driven by a decline in cross-border airfreight solutions, while highlighting strategic progress in pharmaceutical logistics and Asia-based customer growth.

Lakeside Holding Limited has announced the resignation of its Chief Operating Officer, Shuai Li, and the appointment of Lan Su as the new COO, both effective December 9, 2024.

Lakeside Holding's first quarter of fiscal year 2025 saw a slight revenue decrease overall, but a significant increase in revenue from Asia-based customers.

Lakeside Holding Limited's subsidiary, Sichuan Hupan, has agreed to acquire 100% of Hupan Pharmaceutical for RMB 4.0 million (approximately $0.6 million USD).

Lakeside Holding Limited reported a 42.3% increase in total revenue for fiscal year 2024, driven by a significant surge in airfreight revenues.